Lung cancer is responsible for a greater number of cancer deaths than breast, pancreatic, and colon cancer combined. In fact, according to clinical
trials such as the National Lung Screening Trial and the NELSON trial, introducing a periodic lung screening CT for current and former smokers who meet
specific risk criteria could reduce mortality by at least 20%. Unfortunately, lung cancer screening adoption rates remain low.
Introducing a holistic solution addressing the core challenges in the adoption - equity/access,
education, and economics. The WVU Cancer Institute, through WVU Hospitals, is collaborating with Canon Medical Systems USA, Inc. and the Lung Cancer
Initiative at Johnson & Johnson* to overcome healthcare disparities in lung cancer. Beyond its immediate goal of saving lives, the intent is to create a pilot project that can serve as a national model.